Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levulan PDT for AK and NMSC prevention in organ transplant recipients
NCT00865878Phase 2Terminated
- Sponsor
- DUSA Pharmaceuticals
- Start
- May 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aminolevulinic acid 10% gel in actinic keratosis (AK), non-melanoma skin cancer (NMSC), sponsored by DUSA Pharmaceuticals. Started May 2009; status: terminated.
02
Drugs
aminolevulinic acid 10% gel
03
Conditions
actinic keratosis (AK)non-melanoma skin cancer (NMSC)
Beyond the preview
Go deeper on NCT00865878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00865878.